Genomic

New investments will support the implementation of genomic information in practice

January 11, 2023 4 minute read Source/Disclosures Disclosures: Valverde and Rader report no relevant financial information ADD A SUBJECT TO EMAIL ALERTS Receive an email when new articles are published on Please provide your email address to receive an email when new articles are published on . ” data-action=subscribe> Subscribe We have not been able …

New investments will support the implementation of genomic information in practice Read More »

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Claire M. Fraser, Ph.D., to its Board of Directors. Dr. Fraser will begin serving on the Seres Board of Directors, effective immediately. “It is an incredibly exciting time to join Seres’ Board of Directors as the company prepares for its first potential product …

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces Progress of Phase 1b SER-155 Study Read More »